These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 16487951

  • 1. Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index.
    Fabris C, Smirne C, Toniutto P, Colletta C, Rapetti R, Minisini R, Falleti E, Pirisi M.
    Clin Biochem; 2006 Apr; 39(4):339-43. PubMed ID: 16487951
    [Abstract] [Full Text] [Related]

  • 2. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M.
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [Abstract] [Full Text] [Related]

  • 3. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
    Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, Bauer B, Stauber RE.
    Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
    Vardar R, Vardar E, Demiri S, Sayhan SE, Bayol U, Yildiz C, Postaci H.
    Hepatogastroenterology; 2009 Jun; 56(94-95):1459-65. PubMed ID: 19950810
    [Abstract] [Full Text] [Related]

  • 6. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
    Snyder N, Nguyen A, Gajula L, Soloway R, Xiao SY, Lau DT, Petersen J.
    Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
    [Abstract] [Full Text] [Related]

  • 7. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
    Cheung RC, Currie S, Shen H, Bini EJ, Ho SB, Anand BS, Hu KQ, Wright TL, Morgan TR, VA HCV-001 Study Group.
    J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
    [Abstract] [Full Text] [Related]

  • 8. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection.
    Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T.
    Am J Gastroenterol; 2001 Nov; 96(11):3142-6. PubMed ID: 11721762
    [Abstract] [Full Text] [Related]

  • 9. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M, Penaranda G, Renou C, Botta-Fridlund D, Tran A, Portal I, Lecomte L, Castellani P, Rosenthal-Allieri MA, Gerolami R, Ouzan D, Deydier R, Degott C, Halfon P.
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
    Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH.
    Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
    [Abstract] [Full Text] [Related]

  • 11. Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C.
    Shaikh S, Memon MS, Ghani H, Baloch GH, Jaffery M, Shaikh K.
    J Coll Physicians Surg Pak; 2009 Aug; 19(8):478-82. PubMed ID: 19651008
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Non-invasive models for predicting histology in patients with chronic hepatitis B.
    Wai CT, Cheng CL, Wee A, Dan YY, Chan E, Chua W, Mak B, Oo AM, Lim SG.
    Liver Int; 2006 Aug; 26(6):666-72. PubMed ID: 16842322
    [Abstract] [Full Text] [Related]

  • 14. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.
    Sheth SG, Flamm SL, Gordon FD, Chopra S.
    Am J Gastroenterol; 1998 Jan; 93(1):44-8. PubMed ID: 9448172
    [Abstract] [Full Text] [Related]

  • 15. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
    Parise ER, Oliveira AC, Figueiredo-Mendes C, Lanzoni V, Martins J, Nader H, Ferraz ML.
    Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
    [Abstract] [Full Text] [Related]

  • 16. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    Sebastiani G, Vario A, Guido M, Alberti A.
    J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453
    [Abstract] [Full Text] [Related]

  • 17. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
    Carvalho-Filho RJ, Schiavon LL, Narciso-Schiavon JL, Sampaio JP, Lanzoni VP, Ferraz ML, Silva AE.
    Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.
    Sulkowski MS, Mehta SH, Torbenson MS, Higgins Y, Brinkley SC, de Oca RM, Moore RD, Afdhal NH, Thomas DL.
    AIDS; 2007 Oct 18; 21(16):2209-16. PubMed ID: 18090048
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.